Exbivirumab

Exbivirumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
Targethepatitis B surface antigen
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC6416H9924N1732O1982S44
Molar mass144446.75 g·mol−1
 ☒NcheckY (what is this?)  (verify)

Exbivirumab is a human monoclonal antibody[1] developed for the treatment of hepatitis B infections.[2]

References

  1. ↑ "WHO Drug Information" (PDF). Archived from the original (PDF) on 2011-05-11. Retrieved 2009-09-24.
  2. ↑ Shouval D, Terrault N, Galun E, Samuel D, Gane E, Pruett T, et al. (2006). "Anti-Viral Effects, Pharmacokinetics and Safety of Two Human Monoclonal Anti-Hbs (Libivirumab/Exbivirumab) Versus Hepatitis B Immune Globulin (Hbig) in Hepatitis B Virus (Hbv) in Liver Transplant (Lt) Recipients". Hepatology. 44 (4): 188A–700A [196A]. doi:10.1002/hep.21395.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.